DK3484587T3 - Kombination, der omfatter zidovudin og et carbapenem - Google Patents

Kombination, der omfatter zidovudin og et carbapenem Download PDF

Info

Publication number
DK3484587T3
DK3484587T3 DK17743070.9T DK17743070T DK3484587T3 DK 3484587 T3 DK3484587 T3 DK 3484587T3 DK 17743070 T DK17743070 T DK 17743070T DK 3484587 T3 DK3484587 T3 DK 3484587T3
Authority
DK
Denmark
Prior art keywords
zidovudin
carbapenem
combination including
combination
including zidovudin
Prior art date
Application number
DK17743070.9T
Other languages
English (en)
Inventor
Anthony Coates
Yanmin Hu
Original Assignee
Helperby Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helperby Therapeutics Ltd filed Critical Helperby Therapeutics Ltd
Application granted granted Critical
Publication of DK3484587T3 publication Critical patent/DK3484587T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK17743070.9T 2016-07-12 2017-07-11 Kombination, der omfatter zidovudin og et carbapenem DK3484587T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1612093.3A GB201612093D0 (en) 2016-07-12 2016-07-12 Combination
PCT/GB2017/052030 WO2018011562A1 (en) 2016-07-12 2017-07-11 Combination comprising zidovudine and a carbapenem

Publications (1)

Publication Number Publication Date
DK3484587T3 true DK3484587T3 (da) 2021-10-25

Family

ID=56890874

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17743070.9T DK3484587T3 (da) 2016-07-12 2017-07-11 Kombination, der omfatter zidovudin og et carbapenem

Country Status (10)

Country Link
US (1) US10888575B2 (da)
EP (1) EP3484587B1 (da)
JP (2) JP7332155B2 (da)
CN (1) CN110022937A (da)
CA (1) CA3030532C (da)
DK (1) DK3484587T3 (da)
GB (1) GB201612093D0 (da)
PL (1) PL3484587T3 (da)
PT (1) PT3484587T (da)
WO (1) WO2018011562A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201704620D0 (en) * 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
GB201807046D0 (en) 2018-04-30 2018-06-13 Helperby Therapeutics Ltd Combination
GB201913068D0 (en) 2019-09-10 2019-10-23 Helperby Therapeutics Ltd Combination
GB201914847D0 (en) 2019-10-14 2019-11-27 Helperby Therapeutics Ltd Combination
CN114196586B (zh) * 2021-12-20 2023-04-11 郑州大学 一株蒙氏肠球菌及其在发酵中草药中的应用
GB202213750D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial
GB202213753D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial combinations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1061100A (en) 1998-11-09 2000-05-29 St. George's Enterprises Limited Screening process for antibacterial agents
CA2416512C (en) 2000-07-19 2010-10-19 Pitmy International N.V. Enhancement of the action of anti-infective agents
US7087401B2 (en) * 2002-06-20 2006-08-08 3M Innovative Properties Company Culture medium and method for detecting thermonuclease-positive staphylococci
BRPI0413372A (pt) 2003-08-08 2006-10-17 Ulysses Pharmaceutical Product composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos
US9096649B2 (en) * 2008-02-08 2015-08-04 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
CA2717737A1 (en) * 2008-03-07 2009-09-11 Lectec Corporation Hand sanitizing patch
EP2571493A1 (de) * 2010-05-21 2013-03-27 Basf Se ZUBEREITUNGEN BIOLOGISCH AKTIVER SUBSTANZEN MIT VERGRÖßERTER OBERFLÄCHE AUF BASIS VON AMPHIPHILEN COPOLYMEREN
US20130131628A1 (en) * 2011-10-24 2013-05-23 The Board Of Regents Of The University Of Texas System Device and method for sustained release of therapeutic agent
GB201305277D0 (en) * 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201401617D0 (en) * 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use

Also Published As

Publication number Publication date
CA3030532C (en) 2023-06-20
JP2023040144A (ja) 2023-03-22
GB201612093D0 (en) 2016-08-24
WO2018011562A1 (en) 2018-01-18
EP3484587B1 (en) 2021-09-01
CN110022937A (zh) 2019-07-16
PL3484587T3 (pl) 2022-01-24
CA3030532A1 (en) 2018-01-18
US10888575B2 (en) 2021-01-12
EP3484587A1 (en) 2019-05-22
US20190321384A1 (en) 2019-10-24
JP7332155B2 (ja) 2023-08-23
JP2019521135A (ja) 2019-07-25
PT3484587T (pt) 2021-10-19

Similar Documents

Publication Publication Date Title
DK3411358T3 (da) Substitueret piperidinforbindelse og anvendelse deraf.
DK3307707T3 (da) Halogensubstituerede phenoxyphenylamidiner og anvendelsen deraf som fungicider
DK3360878T3 (da) Azetidinderivat, fremstillingsfremgangsmåde derfor og anvendelse deraf
DK2980328T3 (da) Nedsivningsblokelement, nedsivningsblok og transportenhed
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3484587T3 (da) Kombination, der omfatter zidovudin og et carbapenem
DK3504506T3 (da) Mål
DK3103715T3 (da) Styreindretning og styringsfremgangsmåde dertil
DK3395801T3 (da) Arylazolforbindelse og skadedyrsbekæmpelsesmiddel
DK3148584T3 (da) Kombination, der omfatter et glucocorticoid og edo-s101
DK3612579T3 (da) Pultrudat, fremstilling og anvendelse heraf
DK3288825T3 (da) Teleskopisk adgangsbro, enhed forsynet hermed og tilhørende fremgangsmåde
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3156181T3 (da) Sikkerhedsindretning og værktøj
DK3386956T3 (da) Fumagillolderivater og polymorfer deraf
DK3679258T3 (da) Indretning med et leje-i-lejet.
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
DK3337506T3 (da) Kombinationer og anvendelser deraf
DK3371163T3 (da) Pyrrolidinderivater
DK3263133T3 (da) Pyridinonforbindelse og anvendelse deraf
FR3046841B1 (fr) Couplemetre a torsion
DK3391870T3 (da) Pneumomassagehylster
DK3513935T3 (da) Skæreindretning og fremstillingsindretning, der omfatter en sådan skæreindretning
MA46201A (fr) Un linteau